The stock of Concordia International Corp (TSE:CXR) is a huge mover today! About 670,652 shares traded hands. Concordia International Corp (TSE:CXR) has declined 88.97% since April 8, 2016 and is downtrending. It has underperformed by 93.96% the S&P500.
The move comes after 6 months positive chart setup for the $276.94M company. It was reported on Nov, 14 by Barchart.com. We have $8.12 PT which if reached, will make TSE:CXR worth $243.71M more.
Concordia International Corp (TSE:CXR) Ratings Coverage
Out of 4 analysts covering Concordia Healthcare Corp (TSE:CXR), 0 rate it a “Buy”, 0 “Sell”, while 4 “Hold”. This means 0 are positive. $135 is the highest target while $2 is the lowest. The $28.40 average target is 557.41% above today’s ($4.32) stock price. Concordia Healthcare Corp has been the topic of 26 analyst reports since August 11, 2015 according to StockzIntelligence Inc. The rating was maintained by RBC Capital Markets on Tuesday, June 7 with “Outperform”. The rating was maintained by RBC Capital Markets with “Outperform” on Friday, January 8. The firm has “Outperform” rating by RBC Capital Markets given on Monday, June 20. On Friday, July 22 the stock rating was maintained by Goldman Sachs with “”. The firm has “Outperform” rating given on Monday, October 17 by RBC Capital Markets. Scotia Capital maintained it with “Sector Outperform” rating and $100 target price in Wednesday, September 9 report. RBC Capital Markets maintained it with “Outperform” rating and $118 target price in Tuesday, August 11 report. The stock of Concordia International Corp (TSE:CXR) has “Outperform” rating given on Tuesday, October 11 by RBC Capital Markets. The rating was maintained by RBC Capital Markets on Monday, October 31 with “Outperform”. The rating was maintained by RBC Capital Markets on Monday, May 16 with “Outperform”.
More recent Concordia International Corp (TSE:CXR) news were published by: Finance.Yahoo.com which released: “Concordia International Corp. Announces Communication With CMA” on October 25, 2016. Also Finance.Yahoo.com published the news titled: “Concordia International Corp. Announces CEO Transition Plan” on October 21, 2016. Prnewswire.com‘s news article titled: “Shareholder Class Action Filed Against Concordia International Corp. – CXRX” with publication date: August 17, 2016 was also an interesting one.
Concordia International Corp, formerly Concordia Healthcare Corp, is a Canada pharmaceutical company. The company has a market cap of $276.94 million. The Company, through subsidiaries, owns a portfolio of branded and generic prescription products. It currently has negative earnings.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.